Oxford Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-19,358
| Closed | -$101K | – | 375 |
|
|
2023
Q4 | $101K | Buy |
+19,358
| New | +$101K | 0.15% | 159 |
|
|
2020
Q1 | – | Sell |
-10,873
| Closed | -$653K | – | 1399 |
|
|
2019
Q4 | $653K | Sell |
10,873
-21,012
| -66% | -$1.26M | 0.02% | 1096 |
|
|
2019
Q3 | $1.8M | Sell |
31,885
-27,831
| -47% | -$1.57M | 0.04% | 607 |
|
|
2019
Q2 | $3.33M | Buy |
+59,716
| New | +$3.33M | 0.07% | 411 |
|
|
2018
Q4 | – | Sell |
-40,852
| Closed | -$2.83M | – | 2166 |
|
|
2018
Q3 | $2.83M | Buy |
+40,852
| New | +$2.83M | 0.06% | 469 |
|
|
2018
Q2 | – | Sell |
-5,296
| Closed | -$279K | – | 1973 |
|
|
2018
Q1 | $279K | Sell |
5,296
-56,399
| -91% | -$2.97M | 0.01% | 1421 |
|
|
2017
Q4 | $3.31M | Buy |
61,695
+36,331
| +143% | +$1.95M | 0.07% | 338 |
|
|
2017
Q3 | $1.51M | Buy |
25,364
+14,810
| +140% | +$879K | 0.03% | 761 |
|
|
2017
Q2 | $833K | Sell |
10,554
-8,241
| -44% | -$650K | 0.02% | 946 |
|
|
2017
Q1 | $1.56M | Buy |
+18,795
| New | +$1.56M | 0.04% | 607 |
|